Our aim is to derive value from innovation by building a dynamic technology-based company that devises and applies cutting-edge science, particularly in the field of catalysis, in order to provide high quality solutions to our customers that are instrumental in assisting them to meet their business goals.
- To become an established partner for outsourcing chemcial research and development activities with at least five of the top ten innovator pharma companies by 2015
- To develop a high value IP portfolio through the in-house R&D programme to enable the launch at least one innovative, commercially attractive product by 2016 and three by 2018
- To deliver a strong pipeline of potential customers that will ensure year on year increase in revenue with the right mix of fee for service and shared risk/reward projects
- To establish further technical and commercial partnerships that improve our capability and capacity to provide value-adding solutions, broaden our commercial reach and support business growth
- To provide an excellent return for investors